 |
 |

Clinical Trial Registration and the ICMJE
 |
 |
| Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings. |
|
 |
 |
To the Editor: Calls to establish a comprehensive clinical trial registry1-2 are welcome. As registry supporters point out, the failure to publicize full trial data denies physicians and patients valuable information and unjustifiably diminishes the contributions of researchers and trial participants.
The lack of a comprehensive trial registry has another negative consequence: it fosters the general perception that investigational interventions are better than existing alternatives. When this perception guides patients, they enroll in trials assuming that they will receive cutting-edge therapy. If negative and inconclusive trial results were widely reported, the public would receive an accurate picture of medicines slow and incremental advances. Such reporting could also raise awareness that research is done to advance knowledge, not to provide individual trial participants with the best treatment.3
In 1997, Congress directed health officials to establish www.clinicaltrials.gov as a national registry so that patients could locate trials relevant to their conditions. Unfortunately, . . . [Full Text of this Article]
Rebecca Dresser, JD
dresser@wulaw.wustl.edu Washington University School of Law St Louis, Mo
RELATED ARTICLES
Clinical Trial Registration and the ICMJE
Omar Khalil, Rangaswamy Govindarajan, Mazin Safar, Laura Hutchins, and Paulette Mehta
JAMA. 2005;293(2):157.
EXTRACT
| FULL TEXT
Clinical Trial Registration and the ICMJE
Marc G. H. Besselink, Hein G. Gooszen, and Erik Buskens
JAMA. 2005;293(2):157-158.
EXTRACT
| FULL TEXT
Clinical Trial Registration and the ICMJEReply
Catherine D. DeAngelis
JAMA. 2005;293(2):158.
EXTRACT
| FULL TEXT
Clinical Trial Registration: A Statement From the International Committee of Medical Journal Editors
Catherine D. DeAngelis, Jeffrey M. Drazen, Frank A. Frizelle, Charlotte Haug, John Hoey, Richard Horton, Sheldon Kotzin, Christine Laine, Ana Marusic, A. John P. M. Overbeke, Torben V. Schroeder, Hal C. Sox, and Martin B. Van Der Weyden
JAMA. 2004;292(11):1363-1364.
EXTRACT
| FULL TEXT
|